Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Lung Adenocarcinoma (MSKCC, Science 2015)	CA9903	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	F853C	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: yes;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.998	Missense_Mutation	SNP			NA	NA	NA	9	139405633	139405633	A	C	9:g.139405633A>C	ENST00000277541.6:c.2558T>G	0.21		18	66		45	318	16/34					3	57	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Progression-free Survival	0.9484	Adenocarcinoma	Transversion High	226	324	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	14.5	3	1	Male	Former	80	Matched	10.5666666667	494	PR																																																	
Lung Adenocarcinoma (MSKCC, Science 2015)	CA9903	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	F853I	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: yes;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.997	Missense_Mutation	SNP			NA	NA	NA	9	139405634	139405634	A	T	9:g.139405634A>T	ENST00000277541.6:c.2557T>A	0.21		17	65		44	318	16/34					3	57	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Progression-free Survival	0.9484	Adenocarcinoma	Transversion High	226	324	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	14.5	3	1	Male	Former	80	Matched	10.5666666667	494	PR																																																	
Non-small cell lung cancer (MSK, Science 2015)	CA9903	Lung cancer	Lung Adenocarcinoma	F853C	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: yes;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.998	Missense_Mutation	SNP			Somatic	NA	MSKCC	9	139405633	139405633	A	C	9:g.139405633A>C	ENST00000277541.6:c.2558T>G							318	16/34								DCB			Adenocarcinoma	Transversion High	226	324		LUAD	Strong	14.5	3	1	Male	Former		Matched	10.5333333333	494												Tumor			Primary							57	10	71.664856	118.675283	Partial Response	1:Event	FFPE	80.0	Lung	3																			
Non-small cell lung cancer (MSK, Science 2015)	CA9903	Lung cancer	Lung Adenocarcinoma	F853I	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: yes;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.997	Missense_Mutation	SNP			Somatic	NA	MSKCC	9	139405634	139405634	A	T	9:g.139405634A>T	ENST00000277541.6:c.2557T>A							318	16/34								DCB			Adenocarcinoma	Transversion High	226	324		LUAD	Strong	14.5	3	1	Male	Former		Matched	10.5333333333	494												Tumor			Primary							57	10	71.664856	118.675283	Partial Response	1:Event	FFPE	80.0	Lung	3																			
Lung Adenocarcinoma (MSKCC, Science 2015)	GR4788	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X419_splice	OncoKB: Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP			NA	NA	NA	9	139412588	139412588	C	A	9:g.139412588C>A	ENST00000277541.6:c.1255+1G>T	0.20		2	8		20	165						2	59	Pembrolizumab (Dose 10 mg/kg)	No durable benefit	Progression-free Survival	0.9249	Squamous Cell Carcinoma	Transversion High	51	170	Self reported self status	LUAD	Negative(<1% membraneous staining)	1.9	0	1	Male	Current	45	Matched	5.5	255	POD																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0002252-T01-IM3	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	A1741Rfs*57	OncoKB: Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	Unknown	MSKCC	9	139396887	139396887	C	-	9:g.139396887del	ENST00000277541.6:c.5221del	0.92		660	56		297	15	28/34						73		NO		0.6551						LUSC		4.27		1	Female			Matched	16.637329509					IMPACT341																							1:Progressed																	0.66	Commercial	2	15.30612245		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0009202-T01-IM5	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	Q184Rfs*93	OncoKB: Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	Unknown	MSKCC	9	139417493	139417493	T	-	9:g.139417493del	ENST00000277541.6:c.551del	0.44		252	320		372	12	4/34						66		NE		0.2907						LUSC		3.47		1	Male			Matched	11.7446363714					IMPACT410																							0:Not Progressed																	0.29	Commercial	2	11.32075472	60	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s62	Lung cancer	Lung Adenocarcinoma	Q1547*	OncoKB: Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Nonsense_Mutation	SNP		2	NA	NA	MSKCC	9	139399504	139399504	G	A	9:g.139399504G>A	ENST00000277541.6:c.4639C>T	0.17		32	153			1495	26/34								Durable Clinical Benefit			Non-Squamous			1336		LUAD		22.9979		1	Male			Matched	49.9																												1:Event					87	PR	0	A*02:01	A*01:01	B*57:01	B*51:01	C*05:01	C*06:02	20.0	2297	Never							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003125-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E848*	OncoKB: Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid		SOMATIC	NA	MSKCC	9	139405643	139405650	AGTCCTCG	-	9:g.139405643_139405650del	ENST00000277541.6:c.2541_2548del							3	16/34						42		YES		0.1812						LUAD				1	Male	Never		Matched	2.93615909284			YES	RET	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	348	YES	Primary		IV	YES	YES	60	AWD																													
Non-small cell lung cancer (MSK, Science 2015)	GR4788	Lung cancer	Lung Squamous Cell Carcinoma	X419_splice	OncoKB: Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP			Somatic	NA	MSKCC	9	139412588	139412588	C	A	9:g.139412588C>A	ENST00000277541.6:c.1255+1G>T							165									NDB			Squamous cell Carcinoma	Transversion High	51	170		LUSC	Negative	1.9	0	1	Male	Current		Matched	5.63333333333	255												Tumor			Met							59	10	131.869851	128.244339	Progression of Disease	1:Event	Frozen	45.0	Bronchus	2																			
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s62	Lung cancer	Lung Adenocarcinoma	P460S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: yes	SIFT: impact: deleterious, score: 0.02;Polyphen-2: impact: probably_damaging, score: 1	Missense_Mutation	SNP		2	NA	NA	MSKCC	9	139412267	139412267	G	A	9:g.139412267G>A	ENST00000277541.6:c.1378C>T	0.14		34	207			1495	8/34			rs1266989706					Durable Clinical Benefit			Non-Squamous			1336		LUAD		22.9979		1	Male			Matched	49.9																												1:Event					87	PR	0	A*02:01	A*01:01	B*57:01	B*51:01	C*05:01	C*06:02	20.0	2297	Never							
Lung Adenocarcinoma (MSKCC, Science 2015)	CA9903	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S852R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: benign, score: 0.018	Missense_Mutation	SNP			NA	NA	NA	9	139405635	139405635	G	C	9:g.139405635G>C	ENST00000277541.6:c.2556C>G	0.21		17	63		44	318	16/34				0.000058	3	57	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Progression-free Survival	0.9484	Adenocarcinoma	Transversion High	226	324	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	14.5	3	1	Male	Former	80	Matched	10.5666666667	494	PR																																																	
Lung Adenocarcinoma (MSKCC, Science 2015)	CA9903	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S333R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 1	Missense_Mutation	SNP			NA	NA	NA	9	139413143	139413143	G	C	9:g.139413143G>C	ENST00000277541.6:c.999C>G	0.20		14	56		52	318	6/34					3	57	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Progression-free Survival	0.9484	Adenocarcinoma	Transversion High	226	324	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	14.5	3	1	Male	Former	80	Matched	10.5666666667	494	PR																																																	
Lung Adenocarcinoma (MSKCC, Science 2015)	HE3202	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V2200L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.994	Missense_Mutation	SNP			NA	NA	NA	9	139391593	139391593	C	A	9:g.139391593C>A	ENST00000277541.6:c.6598G>T	0.32		42	90		113	724	34/34					3	63	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Censored	0.9029	Adenocarcinoma	Transversion High	610	746	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	14.7	3	1	Female	Former	58	Matched	24.1333333333	1011	PR																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0007879-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L2065V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.196	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	139391998	139391998	G	C	9:g.139391998G>C	ENST00000277541.6:c.6193C>G	0.13		59	405		309	10	34/34						68		YES		0.4227						LUAD		12.07		1	Female			Matched	9.78719697615					IMPACT410																							1:Progressed																	0.42	Commercial	2	9.433962264	90	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E2071_G2072delinsDC	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	DNP	Diploid		SOMATIC	Unknown	MSKCC	9	139391977	139391978	CC	AA	9:g.139391977_139391978delinsAA	ENST00000277541.6:c.6213_6214delinsTT	0.48		504	539		643	90	34/34						53		YES		0.5235						LUAD		13.17		1	Male			Matched	96.496511152					IMPACT341																							1:Progressed																	0.52	Commercial	2	91.83673469		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0007861-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S137_P143del	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Del	DEL	Diploid		SOMATIC	Unknown	MSKCC	9	139417614	139417634	ACGGGTCAGCCTGCTGGCACG	-	9:g.139417614_139417634del	ENST00000277541.6:c.410_430del	0.08		34	379		311	3	4/34						76		NO		0.0270						LUAD		2.6		1	Female			Matched	2.93615909284					IMPACT410																							1:Progressed																	0.03	Commercial	3	2.830188679	10	Never	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0002637-T01-IM3	Non-Small Cell Lung Cancer	Large Cell Neuroendocrine Carcinoma	Q1076H	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.04;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	139402781	139402781	C	A	9:g.139402781C>A	ENST00000277541.6:c.3228G>T	0.28		227	572		258	17	20/34						53		YES		0.6353						LUNE		27.6		1	Male			Matched	18.8556401102					IMPACT341																							0:Not Progressed																	0.64	Clinical trial	1	17.34693878	0	Ever	Combination
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0004517-T01-IM5	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	R1824L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.998	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	139396454	139396454	C	A	9:g.139396454C>A	ENST00000277541.6:c.5471G>T	0.41		337	488		347	14	29/34						67		NO		0.3808						LUSC		1.67		1	Male			Matched	13.7020757666					IMPACT410																							1:Progressed																	0.38	Commercial	2	14.1509434	0	Never	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0005115-T01-IM5	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	H1544_S1551del	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Del	DEL	Diploid		SOMATIC	Unknown	MSKCC	9	139399491	139399514	CTGTTGCAGCCCTGGTCGCAGTGC	-	9:g.139399491_139399514del	ENST00000277541.6:c.4629_4652del	0.72		390	148		260	2	26/34						55		NO		0.1928						LUSC		1.83		1	Male			Matched	1.95743939523					IMPACT410																							1:Progressed																	0.19	Commercial	2	1.886792453		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0005898-T01-IM5	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	C155S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	139417580	139417580	C	G	9:g.139417580C>G	ENST00000277541.6:c.464G>C	0.22		302	1094		636	4	4/34						71		YES		0.1835						LUSC		12.53		1	Female			Matched	3.91487879046					IMPACT410																							1:Progressed																	0.18	Commercial	2	3.773584906		Never	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0015984-T01-IM6	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	C1472W	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.01;Polyphen-2: impact: probably_damaging, score: 1	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	139399932	139399932	G	C	9:g.139399932G>C	ENST00000277541.6:c.4416C>G	0.48		414	451		713	28	25/34						66		NO		0.6241						LUSC		1.63		1	Female			Matched	24.2115466595					IMPACT468																							1:Progressed																	0.62	Commercial	2	19.67213115	5	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0016033-T01-IM6	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S2423L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.13;Polyphen-2: impact: benign, score: 0.205	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	139390923	139390923	G	A	9:g.139390923G>A	ENST00000277541.6:c.7268C>T	0.12		134	1013		725	34	34/34						72		NE		0.1663						LUAD		5.5		1	Male			Matched	28.5350371345					IMPACT468																							0:Not Progressed																	0.17	Commercial	1	27.04918033	90	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0014599-T01-IM6	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	G1001C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 1	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	9	139403492	139403492	C	A	9:g.139403492C>A	ENST00000277541.6:c.3001G>T	0.27		230	618		988	17	19/34						63		YES		0.5739						LUSC		8.83		1	Male			Matched	14.6998676147					IMPACT468																							0:Not Progressed																	0.57	Commercial	2	13.93442623		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0014786-T01-IM6	Non-Small Cell Lung Cancer	Non-Small Cell Lung Cancer	R1784W	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.971	Missense_Mutation	SNP	Diploid	1	SOMATIC	Unknown	MSKCC	9	139396758	139396758	G	A	9:g.139396758G>A	ENST00000277541.6:c.5350C>T	0.54	0.0018	172	148	1	541	13	28/34		Uncertain_significance				65		NO		0.5080						NSCLC		1.87		1	Female			Matched	11.2410752348					IMPACT468																							1:Progressed																	0.51	Commercial	2	10.6557377		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s41	Lung cancer	Lung Adenocarcinoma	Q1076H	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.04;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP			NA	NA	MSKCC	9	139402781	139402781	C	A	9:g.139402781C>A	ENST00000277541.6:c.3228G>T	0.16		26	141			901	20/34								Durable Clinical Benefit			Non-Squamous			840		LUAD		13.5359		1	Male			Matched	30.0333333333																												0:Censor					53	CR	0	A*02:01	A*03:01	B*18:01	B*55:01	C*03:03	C*07:01	0.0	2852	Former							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s46	Lung cancer	Lung Adenocarcinoma	R1937L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: possibly_damaging, score: 0.809	Missense_Mutation	SNP		1	NA	NA	MSKCC	9	139395128	139395128	C	A	9:g.139395128C>A	ENST00000277541.6:c.5810G>T	0.19		156	685			342	31/34			rs1278840702					No Durable Benefit			Squamous			312		LUAD		3.3183		1	Male			Matched	11.5666666667																												1:Event					69	SD	1	A*02:01	A*32:01	B*35:01	B*51:01	C*04:01	C*14:02	60.0	1256	Former							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s53	Lung cancer	Lung Adenocarcinoma	T491I	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 1;Polyphen-2: impact: benign, score: 0.06	Missense_Mutation	SNP			NA	NA	MSKCC	9	139411807	139411807	G	A	9:g.139411807G>A	ENST00000277541.6:c.1472C>T	0.09		8	85			263	9/34	0.00000420914		rs755769408					No Durable Benefit			Non-Squamous			209		LUAD		1.3799		1	Female			Matched	8.66666666667																												1:Event					46	PD	1	A*33:01	A*32:03	B*35:01	B*14:02	C*04:01	C*08:02	4.0	347	Former							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0008359-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A1173S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.04;Polyphen-2: impact: possibly_damaging, score: 0.491	Missense_Mutation	SNP	Diploid		UNKNOWN	NA	MSKCC	9	139401883	139401883	C	A	9:g.139401883C>A	ENST00000277541.6:c.3517G>T							12	22/34	0.00000872364		rs753060918			57				0.0011						LUAD				1	Female	Former light		Unmatched	11.7446363714			NO	NF1_truncating	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	440	YES	Primary		IV	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004382-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Y279C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 1	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	139413924	139413924	T	C	9:g.139413924T>C	ENST00000277541.6:c.836A>G							38	5/34						77				0.3902						LUAD				1	Male	Former heavy		Matched	37.1913485094			NO	TSC1/2	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	471	YES	Primary		IV	NO	NO	30	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0007879-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L2065V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.196	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	139391998	139391998	G	C	9:g.139391998G>C	ENST00000277541.6:c.6193C>G							10	34/34						66				0.4227						LUAD				1	Female	Former heavy		Matched	9.78719697615			NO	KRAS	IMPACT410	YES	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	827	YES	Primary		IV	NO	YES		AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001750-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	D1790Y	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	139396740	139396740	C	A	9:g.139396740C>A	ENST00000277541.6:c.5368G>T							6	28/34						59		YES		0.4422						LUAD				1	Female	Never		Matched	6.65493180359			NO	EGFR	IMPACT341	NO	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	899	NO	Metastasis		IV	YES	NO	60	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002187-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	D1833N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.16;Polyphen-2: impact: benign, score: 0.006	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	139396341	139396341	C	T	9:g.139396341C>T	ENST00000277541.6:c.5497G>A							9	30/34						72				0.4392						LUAD				1	Male	Former heavy		Matched	9.98239770538			NO	NF1_truncating	IMPACT341	NO	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	824	NO	Metastasis		IV	NO	YES	50	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0000641-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	D452E	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 1	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	139412289	139412289	G	T	9:g.139412289G>T	ENST00000277541.6:c.1356C>A							1	8/34						66				0.2478						LUAD				1	Male	Former heavy		Matched	1.1091553006			NO	MDM2_AMP	IMPACT341	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	611	YES	Primary		IV	NO	YES	30	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002016-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	C1505G	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	139399835	139399835	A	C	9:g.139399835A>C	ENST00000277541.6:c.4513T>G							23	25/34						71				0.3955						LUAD				1	Male	Former heavy		Matched	25.5105719137			NO	CDKN2A loss	IMPACT341	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	331	YES	Primary		IV	NO	YES	30	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004615-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E2071D	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.005	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	139391978	139391978	C	A	9:g.139391978C>A	ENST00000277541.6:c.6213G>T							15	34/34						63				0.2480						LUAD				1	Female	Former heavy		Matched	14.6807954642			NO	MET AMP	IMPACT410	NO	MSKCC	0	Bone	Adenocarcinoma	Lung	YES	Tumor	514	YES	Metastasis		IV	NO	YES	60	DUK																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001833-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	W2034_A2035delinsCS	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	DNP	Diploid		SOMATIC	NA	MSKCC	9	139393428	139393429	CC	AA	9:g.139393428_139393429delinsAA	ENST00000277541.6:c.6102_6103delinsTT							12	33/34						63		NO		0.0013						LUAD				1	Male	Former heavy		Matched	13.3098636072			NO	MET_AMP	IMPACT341	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	705	YES	Metastasis		IV	YES	YES	40	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001571-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G347S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid	2	UNKNOWN	NA	MSKCC	9	139413103	139413103	C	T	9:g.139413103C>T	ENST00000277541.6:c.1039G>A							17	6/34	0.0000123354		rs746187371			65				0.5526						LUAD				1	Female	Former heavy		Matched	17.7464848096			NO	KRAS	IMPACT341	NO	MSKCC	1	Liver	Adenocarcinoma	Lung	YES	Tumor	955	NO	Metastasis		IV	NO	YES	40	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002631-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A1552E	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.98;Polyphen-2: impact: probably_damaging, score: 0.973	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	9	139399488	139399488	G	T	9:g.139399488G>T	ENST00000277541.6:c.4655C>A							6	26/34						67				0.0227						LUAD				1	Female	Former heavy		Matched	6.65493180359			NO	KRAS	IMPACT341	NO	MSKCC	1		Adenocarcinoma	Lung	YES	Tumor	592	NO	Primary		IIA	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001171-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E2071_G2072delinsDC	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	DNP	Diploid		SOMATIC	NA	MSKCC	9	139391977	139391978	CC	AA	9:g.139391977_139391978delinsAA	ENST00000277541.6:c.6213_6214delinsTT							90	34/34						51				0.5235						LUAD				1	Male	Former heavy		Matched	96.496511152			YES	PIK3CA	IMPACT341	YES	MSKCC	1	Adrenal Gland	Adenocarcinoma	Lung	YES	Tumor	1189	NO	Metastasis		IIIA	NO	YES	60	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009924-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q1400_G1401delinsHW	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	DNP	Diploid		SOMATIC	NA	MSKCC	9	139400147	139400148	CC	AA	9:g.139400147_139400148delinsAA	ENST00000277541.6:c.4200_4201delinsTT							18	25/34						78				0.0000						LUAD				1	Male	Former heavy		Matched	17.6169545571			NO	KRAS	IMPACT410	NO	MSKCC	0	Pleura	Adenocarcinoma	Lung	YES	Tumor	982	YES	Metastasis	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	IV	NO	YES	70	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0007861-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	S137_P143del	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Del	DEL	Diploid		SOMATIC	NA	MSKCC	9	139417614	139417634	ACGGGTCAGCCTGCTGGCACG	-	9:g.139417614_139417634del	ENST00000277541.6:c.410_430del							3	4/34						73				0.0270						LUAD				1	Female	Never		Matched	2.93615909284			NO	PIK3CA	IMPACT410	YES	MSKCC	2	Pleura	Adenocarcinoma	Lung	YES	Tumor	712	NO	Metastasis		IV	NO	YES	75	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009856-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	C359F	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.01;Polyphen-2: impact: probably_damaging, score: 0.998	Missense_Mutation	DNP	Diploid		SOMATIC	NA	MSKCC	9	139413065	139413066	GC	AA	9:g.139413065_139413066delinsAA	ENST00000277541.6:c.1076_1077delinsTT							9	6/34						59				0.2005						LUAD				1	Female	Former heavy		Matched	8.80847727853			NO	KRAS	IMPACT410	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	1061	YES	Metastasis		IV	NO	YES	60	AWD																													
Non-small cell lung cancer (MSK, Science 2015)	CA9903	Lung cancer	Lung Adenocarcinoma	S852R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: benign, score: 0.018	Missense_Mutation	SNP			Somatic	NA	MSKCC	9	139405635	139405635	G	C	9:g.139405635G>C	ENST00000277541.6:c.2556C>G							318	16/34				0.000058				DCB			Adenocarcinoma	Transversion High	226	324		LUAD	Strong	14.5	3	1	Male	Former		Matched	10.5333333333	494												Tumor			Primary							57	10	71.664856	118.675283	Partial Response	1:Event	FFPE	80.0	Lung	3																			
Non-small cell lung cancer (MSK, Science 2015)	CA9903	Lung cancer	Lung Adenocarcinoma	S333R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 1	Missense_Mutation	SNP			Somatic	NA	MSKCC	9	139413143	139413143	G	C	9:g.139413143G>C	ENST00000277541.6:c.999C>G							318	6/34								DCB			Adenocarcinoma	Transversion High	226	324		LUAD	Strong	14.5	3	1	Male	Former		Matched	10.5333333333	494												Tumor			Primary							57	10	71.664856	118.675283	Partial Response	1:Event	FFPE	80.0	Lung	3																			
Non-small cell lung cancer (MSK, Science 2015)	HE3202	Lung cancer	Lung Adenocarcinoma	V2200L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.994	Missense_Mutation	SNP			Somatic	NA	MSKCC	9	139391593	139391593	C	A	9:g.139391593C>A	ENST00000277541.6:c.6598G>T							725	34/34								DCB			Adenocarcinoma	Transversion High	610	746		LUAD	Strong	14.7	3	1	Female	Former		Matched	24.0333333333	1011												Tumor			Met							63	10	89.139081	189.705252	Partial Response	0:Censure	FFPE	58.0	Lymph node	3																			
